RXO, Inc. (NYSE:RXO) Receives $26.47 Average Price Target from Analysts

RXO, Inc. (NYSE:RXOGet Free Report) has been given a consensus rating of “Hold” by the seventeen research firms that are currently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and three have issued a buy rating on the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $26.47.

A number of equities research analysts have issued reports on the stock. Wells Fargo & Company reiterated an “equal weight” rating and set a $31.00 price objective on shares of RXO in a research note on Monday, November 11th. The Goldman Sachs Group reiterated a “neutral” rating and set a $29.00 price target on shares of RXO in a research report on Monday, November 18th. Benchmark reissued a “hold” rating on shares of RXO in a research note on Tuesday, October 15th. Oppenheimer restated an “outperform” rating and set a $31.00 target price on shares of RXO in a research note on Tuesday, September 17th. Finally, Susquehanna decreased their price target on RXO from $16.00 to $12.00 and set a “negative” rating on the stock in a research note on Tuesday, November 12th.

Read Our Latest Research Report on RXO

RXO Trading Down 3.5 %

Shares of NYSE:RXO opened at $27.29 on Wednesday. The business’s 50 day simple moving average is $28.70 and its 200 day simple moving average is $27.21. RXO has a 1 year low of $18.75 and a 1 year high of $32.82. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.33 and a quick ratio of 1.33. The company has a market capitalization of $4.39 billion, a P/E ratio of -13.78, a P/E/G ratio of 16.74 and a beta of 1.32.

RXO (NYSE:RXOGet Free Report) last released its earnings results on Thursday, November 7th. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.01. RXO had a positive return on equity of 1.64% and a negative net margin of 6.81%. The firm had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $956.19 million. During the same period in the prior year, the company posted $0.05 EPS. The company’s revenue was up 6.6% compared to the same quarter last year. On average, research analysts anticipate that RXO will post 0.12 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Wilmington Savings Fund Society FSB acquired a new stake in RXO during the 3rd quarter worth approximately $28,000. Nomura Asset Management Co. Ltd. raised its stake in shares of RXO by 68.7% during the third quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock valued at $39,000 after acquiring an additional 570 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of RXO by 40.0% during the third quarter. GAMMA Investing LLC now owns 1,784 shares of the company’s stock valued at $50,000 after acquiring an additional 510 shares during the last quarter. Canada Pension Plan Investment Board acquired a new position in shares of RXO during the second quarter worth $112,000. Finally, KBC Group NV grew its stake in shares of RXO by 28.1% in the third quarter. KBC Group NV now owns 4,055 shares of the company’s stock worth $114,000 after purchasing an additional 890 shares during the last quarter. Institutional investors and hedge funds own 92.73% of the company’s stock.

About RXO

(Get Free Report

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Featured Stories

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.